These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37332027)

  • 1. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.
    Saadi MI; Nikandish M; Ghahramani Z; Valandani FM; Ahmadyan M; Hosseini F; Rahimian Z; Jalali H; Tavasolian F; Abdolyousefi EN; Kheradmand N; Ramzi M
    J Egypt Natl Canc Inst; 2023 Jun; 35(1):18. PubMed ID: 37332027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
    Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
    Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
    Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
    Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
    Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
    Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
    Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
    Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
    Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
    Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT.
    Fan ZY; Han TT; Zuo W; Zhao XS; Chang YJ; Lv M; Mo XD; Sun YQ; Zhang YY; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XY
    Clin Exp Immunol; 2022 Jun; 208(3):332-339. PubMed ID: 35551362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia.
    Lu Y; Wu D; Wang J; Li Y; Ma D; Chai X; Kang Q
    Cell Physiol Biochem; 2016; 39(4):1495-502. PubMed ID: 27606430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between Plasma microRNA Expression and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
    Hu B; Fu W; Huang SY; Gao XT; Li DH; Yan XQ; Zhang YP; Liu Q; Liu L; Liang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):827-32. PubMed ID: 27342518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group.
    Bueno F; Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Martín Calvo C; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Duarte R; Piñana JL; Navarro D;
    Transpl Infect Dis; 2021 Aug; 23(4):e13627. PubMed ID: 33908148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus DNA load monitoring in stool specimens for anticipating the occurrence of intestinal acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: Is it of any value?
    Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Gómez MD; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
    Transpl Infect Dis; 2020 Dec; 22(6):e13440. PubMed ID: 32772456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
    Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.
    Saadi MI; Yaghobi R; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
    Mol Biol Rep; 2013 Oct; 40(10):5833-42. PubMed ID: 24057239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
    Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
    Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.
    Atarod S; Norden J; Bibby LA; Janin A; Ratajczak P; Lendrem C; Pearce KF; Wang XN; O'Reilly S; Van Laar JM; Collin M; Dickinson AM; Crossland RE
    Front Immunol; 2018; 9():1485. PubMed ID: 30042760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma MiR-181b and MiR-194 As Biomarkers for Acute Graft- Versus-Host Disease and Significance of Their Changes].
    Chen Y; Deng HL; Kang DL; Wang Y; Hong XL; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):957-962. PubMed ID: 34105500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.